Empaglutine Duo Tablet 12.5/500 mg
Empagliflozin 12.5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Shinpoong Pharmaceutical Co., Ltd.
MFDS item code 202302563 · Approved 2023.08.30
Improvement of glycemic control in adults with type 2 diabetes mellitus
This medication is used to improve blood sugar control in adults with type 2 diabetes by supplementing diet and exercise. It is particularly important to consult a healthcare professional for patients whose blood sugar is not sufficiently controlled and who have confirmed cardiovascular disease, as caution is needed regarding the occurrence of cardiovascular events. Overall, this medication effectively helps improve blood sugar control in patients with type 2 diabetes.
The recommended dose of this medicine is 1 tablet twice daily. The dose should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of each component: empagliflozin 25 mg and metformin 2000 mg. ⦁ For patients whose blood glucose is not adequately controlled with metformin alone or in combination with other medicines such as insulin, the recommended dose is empagliflozin 5 mg twice daily (total daily dose 10 mg) and the patient's current metformin dose. If empagliflozin 10 mg (total daily dose) is well tolerated but additional glycemic control is needed, the dose may be increased to empagliflozin 25 mg (total daily dose). ⦁ Patients switching to this medicine from combination therapy with empagliflozin (total daily dose 10 mg or 25 mg) and metformin should take their previous doses of empagliflozin and metformin. When this medicine is used concomitantly with a sulfonylurea or insulin, a dose reduction of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use, 4. Adverse Reactions and 6. Interactions). This medicine should be taken with food to reduce gastrointestinal adverse reactions associated with metformin. If you miss a dose, take it as soon as you remember. However, do not take twice the dose at one time; in that case, skip the missed dose. Special populations Patients with renal impairment No dose adjustment is necessary for patients with mild renal impairment. Because this medicine contains metformin, it may be used with dose adjustment in patients with an estimated glomerular filtration rate (eGFR) of 45-59 ml/min/1.73m2 or a CrCl of 45-59 ml/min who do not have other conditions that may increase the risk of lactic acidosis. In these patients, the starting dose of metformin is 500 mg or 850 mg once daily; therefore, treatment should be initiated with the individual components of empagliflozin and metformin. The maximum daily dose of metformin hydrochloride that may be administered with this medicine is 1000 mg, which may be given as 500 mg twice daily. Renal function should be monitored carefully every 3-6 months (see Precautions for Use, 3. Patients Requiring Caution, item 1)). If renal function declines to CrCl < 45 ml/min or eGFR < 45 ml/min/1.73m2, discontinue this medicine immediately (see Precautions for Use, 2. Patients Who Must Not Receive This Medicine, item 2)). Elderly patients In patients aged 75 years and older, renal function and the risk of volume depletion should be considered.
This medication helps control blood sugar levels. However, there are several precautions to be aware of while taking this medication. First, it can rarely cause a serious condition called lactic acidosis, which is a dangerous buildup of lactic acid in the body. Additionally, caution is needed as hypoglycemia may occur when used with other diabetes medications. Patients with poor kidney function, acute kidney issues, heart failure, serious infections, or those scheduled for surgery should not take this medication. Also, it is safest for pregnant or breastfeeding women to avoid using this medication. Regular kidney function tests should be conducted while taking this medication, and if conditions such as dehydration, severe vomiting, or diarrhea occur, immediate consultation with a doctor is necessary. Furthermore, when taken with insulin or other hypoglycemic agents, dose adjustment may be necessary to reduce the risk of hypoglycemia. This medication may increase the risk of urinary tract infections or genital infections, so prompt treatment is required if symptoms of infection appear. Additionally, it may reduce fluid volume, leading to lowered blood pressure, so caution is particularly needed in the elderly or those with cardiovascular conditions. Patients with poor liver function should also avoid this medication, and consumption of alcohol should be limited as it can increase the risk of lactic acidosis. If symptoms such as fever, pain or swelling around the genital area, rash, etc. arise while taking this medication, notify a doctor immediately, and severe cases may require emergency treatment. This medication is not recommended for children, and elderly patients should be monitored frequently for kidney function while taking it. Lastly, if an overdose occurs, immediate medical treatment is necessary, especially if symptoms of lactic acidosis are suspected.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to avoid contact with air or moisture, and it is advised to keep it at room temperature between 1 degree and 30 degrees Celsius. Storing it this way helps maintain the medication's effectiveness for a longer period.
Light brownish-purple, oval, convex, film-coated tablet
10 tablets/box [10 tablets/PTP x 1], 60 tablets/box [10 tablets/PTP x 6], 30 tablets/bottle, 60 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Empagliflozin 12.5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Shinpoong Pharmaceutical Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.